Advertisement
Singapore markets close in 4 hours 57 minutes
  • Straits Times Index

    3,157.98
    -26.93 (-0.85%)
     
  • Nikkei

    39,312.73
    +214.03 (+0.55%)
     
  • Hang Seng

    16,612.54
    -113.32 (-0.68%)
     
  • FTSE 100

    7,706.28
    +21.79 (+0.28%)
     
  • Bitcoin USD

    51,561.11
    -51.15 (-0.10%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,088.80
    +1.77 (+0.03%)
     
  • Dow

    39,131.53
    +62.43 (+0.16%)
     
  • Nasdaq

    15,996.82
    -44.78 (-0.28%)
     
  • Gold

    2,041.50
    -7.90 (-0.39%)
     
  • Crude Oil

    76.06
    -0.43 (-0.56%)
     
  • 10-Yr Bond

    4.2600
    -0.0670 (-1.55%)
     
  • FTSE Bursa Malaysia

    1,549.93
    +0.82 (+0.05%)
     
  • Jakarta Composite Index

    7,288.59
    -6.51 (-0.09%)
     
  • PSE Index

    6,930.95
    +17.74 (+0.26%)
     

Company News for May 10, 2023

  • Shares of Duke Energy Corporation (DUK) declined 0.9% after the company reported first-quarter 2023 earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.29 per share.

  • Lumentum Holdings Inc.’s (LITE) shares fell 4% after the company reported third-quarter fiscal 2023 earnings of $0.75 per share, lagging the Zacks Consensus Estimate of $0.83 per share.

  • Shares of Atkore Inc. (ATKR) gained 0.5% after the company reported second-quarter fiscal 2023 earnings of $4.87 per share, beating the Zacks Consensus Estimate of $4.11 per share.

  • bluebird bio, Inc.’s (BLUE) shares jumped 12.6% after the company reported first-quarter 2023 earnings of $0.21 per share, surpassing the Zacks Consensus Estimate of a loss of $0.54 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Duke Energy Corporation (DUK) : Free Stock Analysis Report

bluebird bio, Inc. (BLUE) : Free Stock Analysis Report

Lumentum Holdings Inc. (LITE) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research